<i id='EEE07B68FB'><strike id='EEE07B68FB'><tt id='EEE07B68FB'><pre id='EEE07B68FB'></pre></tt></strike></i> 
WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.
In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.
advertisement
“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTED Log In
Medicare details structure of new drug price negotiation program 
Ahead of NATO summit, Biden meets with King Charles for 1st time since coronation 
Moonlake's readout produced a cash windfall. Risks remain 
FDA approves Leqembi, a milestone in Alzheimer’s treatment 
In Memoriam: Notable people who died in 2023 
Startup Neumora takes a novel depression drug to Phase 3 
Affirmative action in medical school literally saved lives 
In early work, researchers turn to CRISPR to treat Alzheimer's
Moonlake's readout produced a cash windfall. Risks remain 
How Medicaid coverage policies for immigrants impact new moms 
FDA approval of Sarepta Duchenne genetic therapy gives me hope 
Why Titanic fascinates society, still drawing tours to the wreckage 
Psychedelics group wrestles with new pharma identity 
Masked men burn a market in a Mexican city plagued by gang violence, killing 9 people 
Tori Bowie and the unacceptable rates of Black maternal death 
